← SynDRA
ACALISIB
SynDRA canonical compound SYN0039847 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PIK3CB | PIK3CD |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PI3K inhibitor
Cross-references
Synonyms
- GS-9820
- CAL-120
- CAL120
- GS9820
- GS 9820
- Acalisib [INN]
- CAL 120
- UNII-OVW60IDW1D
- OVW60IDW1D
- ACALISIB [WHO-DD]
- acalisibum
- RefChem:108669
- Acalisib (GS-9820)
- C21H16FN7O
- SCHEMBL356539
- orb1305173
- SCHEMBL17518095
- SCHEMBL29360030
- SCHEMBL29422834
- GTPL10096
- BDBM217352
- GLXC-90107
- EX-A2199
- s5818
- Acalisib; GS-9820; CAL-120
- AKOS030526955
- CS-5556
- NCGC00408915-01
- NCGC00408915-02
- AC-35977
- BS-17755
- FA101029
- HY-12644
- C76844
- BRD-K92517771-001-01-2
Look up ACALISIB in the interactive SynDRA portal →